Name:
Aqualine Matrix K
Synonym:
None
CAS:
67-66-3
Section 1 - Chemical Product
MSDS Name:Aqualine Matrix K
Synonym:None
Synonym:None
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | emsds | EINECS# |
| 67-66-3 | Chloroform | 60-70.0 | 200-663-8 |
| Hazard Symbols: XN Risk Phrases: 37/38 40 48/20/22 |
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to respiratory system and skin. Limited evidence of a carcinogenic effect. Harmful : danger of serious damage to health by prolonged exposure through inhalation and if swallowed.
Potential Health Effects
Eye:
May cause moderate eye irritation. May cause transient corneal injury. Vapors may cause eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin. May cause skin sensitization, an allergic reaction, which becomes evident upon re-exposure to this material. Causes symptoms similar to those of inhalation. May cause severe skin irritation with possible burns, especially if skin is wet or moist.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause systemic toxicity with acidosis. May cause liver and kidney damage. May cause central nervous system depression, characterized by excitement, followed by headache, dizziness, drowsiness, and nausea. Advanced stages may cause collapse, unconsciousness, coma and possible death due to respiratory failure.
May cause cardiac disturbances. Aspiration of material into the lungs may cause chemical pneumonitis, which may be fatal. Harmful or fatal if swallowed May cause bone marrow damage.
Inhalation:
Harmful if inhaled. Inhalation of high concentrations may cause central nervous system effects characterized by nausea, headache, dizziness, unconsciousness and coma. Causes respiratory tract irritation. May cause cardiac sensitization and possible failure.
May cause effects similar to those described for ingestion. May cause lung damage. Heated or misted substance may cause headache, irregular eye movements, and possible coma. May cause anemia. May cause drowsiness, unconsciousness, and central nervous system depression. May be absorbed through the lungs.
Chronic:
Possible cancer hazard based on tests with laboratory animals.
Prolonged or repeated skin contact may cause defatting and dermatitis. May cause reproductive and fetal effects. Effects may be delayed. Toxicity may be increased by exposure to alcohol, steroids, and ketones. Prolonged exposure may cause liver, kidney, and heart damage.
Irritating to respiratory system and skin. Limited evidence of a carcinogenic effect. Harmful : danger of serious damage to health by prolonged exposure through inhalation and if swallowed.
Potential Health Effects
Eye:
May cause moderate eye irritation. May cause transient corneal injury. Vapors may cause eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin. May cause skin sensitization, an allergic reaction, which becomes evident upon re-exposure to this material. Causes symptoms similar to those of inhalation. May cause severe skin irritation with possible burns, especially if skin is wet or moist.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause systemic toxicity with acidosis. May cause liver and kidney damage. May cause central nervous system depression, characterized by excitement, followed by headache, dizziness, drowsiness, and nausea. Advanced stages may cause collapse, unconsciousness, coma and possible death due to respiratory failure.
May cause cardiac disturbances. Aspiration of material into the lungs may cause chemical pneumonitis, which may be fatal. Harmful or fatal if swallowed May cause bone marrow damage.
Inhalation:
Harmful if inhaled. Inhalation of high concentrations may cause central nervous system effects characterized by nausea, headache, dizziness, unconsciousness and coma. Causes respiratory tract irritation. May cause cardiac sensitization and possible failure.
May cause effects similar to those described for ingestion. May cause lung damage. Heated or misted substance may cause headache, irregular eye movements, and possible coma. May cause anemia. May cause drowsiness, unconsciousness, and central nervous system depression. May be absorbed through the lungs.
Chronic:
Possible cancer hazard based on tests with laboratory animals.
Prolonged or repeated skin contact may cause defatting and dermatitis. May cause reproductive and fetal effects. Effects may be delayed. Toxicity may be increased by exposure to alcohol, steroids, and ketones. Prolonged exposure may cause liver, kidney, and heart damage.
Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Possible aspiration hazard. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Causes cardiac sensitization to endogenous catelcholamines which may lead to cardiac arrhythmias. Do NOT use adrenergic agents such as epinephrine or pseudoepinephrine. Ethanol may inhibit methanol metabolism. Effects may be delayed.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Possible aspiration hazard. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Causes cardiac sensitization to endogenous catelcholamines which may lead to cardiac arrhythmias. Do NOT use adrenergic agents such as epinephrine or pseudoepinephrine. Ethanol may inhibit methanol metabolism. Effects may be delayed.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Containers may explode when heated.
Extinguishing Media:
Do NOT use straight streams of water. For small fires, use dry chemical, carbon dioxide, or water spray. For large fires, use water spray, fog or regular foam.
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Containers may explode when heated.
Extinguishing Media:
Do NOT use straight streams of water. For small fires, use dry chemical, carbon dioxide, or water spray. For large fires, use water spray, fog or regular foam.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Do not flush into a sewer. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation. A vapor suppressing foam may be used to reduce vapors.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Do not flush into a sewer. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation. A vapor suppressing foam may be used to reduce vapors.
Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Do not ingest or inhale.
Storage:
Do not store in direct sunlight. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep away from acids. Do not store near alkaline substances.
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Do not ingest or inhale.
Storage:
Do not store in direct sunlight. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep away from acids. Do not store near alkaline substances.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local explosion-proof ventilation to keep airborne levels to acceptable levels.
Exposure Limits CAS# 67-66-3: United Kingdom, WEL - TWA: 2 ppm TWA; 9.9 mg/m3 TWA United Kingdom, WEL - STEL: 6 ppm STEL; 29.7 mg/m3 STEL United States OSHA: ; 50 ppm Ceiling; 240 mg/m3 Ceiling Belgium - TWA: 10 ppm VLE; 50 mg/m3 VLE France - VME: 5 ppm VME; 25 mg/m3 VME France - VLE: 50 ppm VLE; 250 mg/m3 VLE Germany: 4 ppm TWA (large technical manufacture and use); 20 mg/m TWA (large technical m Germany: Skin absorber Japan: 10 ppm OEL; 49 mg/m3 OEL Malaysia: 10 ppm TWA; 49 mg/m3 TWA Netherlands: 5 ppm STEL; 25 mg/m3 STEL Netherlands: 1 ppm MAC; 5 mg/m3 MAC Spain: 2 ppm VLA-ED; 10 mg/m3 VLA-ED CAS# 107-21-1: United Kingdom, WEL - TWA: 20 ppm TWA (vapor); 52 mg/m3 TWA (vapo 10 mg/m3 TWA (particulate) United Kingdom, WEL - STEL: 40 ppm STEL (vapor); 104 mg/m3 STEL (vapor); 30 mg/m3 STEL (particulate) Belgium - TWA: 20 ppm VLE; 52 mg/m3 VLE Belgium - STEL: 40 ppm VLE; 104 mg/m3 VLE France - VLE: 50 ppm VLE (vapor); 125 mg/m3 VLE (vapor) Germany: 10 ppm TWA; 26 mg/m3 TWA Germany: Skin absorber Malaysia: 39.4 ppm Ceiling (aerosol); 100 mg/m3 Ceiling (aerosol) Netherlands: 40 ppm STEL; 104 mg/m3 STEL Netherlands: 20 ppm MAC (fume); 52 mg/m3 MAC (fume); 10 mg/m3 MAC (droplets) Russia: 5 mg/m3 TWA (aerosol, particulate, mist) Spain: 20 ppm VLA-ED; 52 mg/m3 VLA-ED Spain: 40 ppm VLA-EC; 104 mg/m3 VLA-EC CAS# 111-76-2: United Kingdom, WEL - TWA: 25 ppm TWA United Kingdom, WEL - STEL: 50 ppm STEL United States OSHA: 50 ppm TWA; 240 mg/m3 TWA Belgium - TWA: 20 ppm VLE; 98 mg/m3 VLE Belgium - STEL: 50 ppm VLE; 246 mg/m3 VLE France - VME: 25 ppm VME; 120 mg/m3 VME Germany: 20 ppm TWA; 98 mg/m3 TWA Germany: Skin absorber Malaysia: 20 ppm TWA; 96.7 mg/m3 TWA Netherlands: 50 ppm STEL; 246 mg/m3 STEL Netherlands: 20 ppm MAC; 100 mg/m3 MAC Russia: 5 mg/m3 TWA Spain: 20 ppm VLA-ED; 98 mg/m3 VLA-ED Spain: 50 ppm VLA-EC; 245 mg/m3 VLA-EC CAS# 5683-33-0: CAS# 7446-09-5: United States OSHA: 5 ppm TWA; 13 mg/m3 TWA Belgium - TWA: 2 ppm VLE; 5.3 mg/m3 VLE Belgium - STEL: 5 ppm VLE; 13 mg/m3 VLE France - VME: 2 ppm VME; 5 mg/m3 VME France - VLE: 5 ppm VLE; 10 mg/m3 VLE Germany: 1 ppm TWA (paper production, chemical and pharmaceutical industries); 2.5 mg/m3 Malaysia: 2 ppm TWA; 5.2 mg/m3 TWA Netherlands: 2 ppm MAC; 5 mg/m3 MAC Russia: 10 mg/m3 TWA Spain: 2 ppm VLA-ED; 5.3 mg/m3 VLA-ED Spain: 5 ppm VLA-EC; 13 mg/m3 VLA-EC CAS# 7553-56-2: United Kingdom, WEL - STEL: 0.1 ppm STEL; 1.1 mg/m3 STEL United States OSHA: ; 0.1 ppm Ceiling; 1 mg/m3 Ceiling Belgium - TWA: 0.1 ppm VLE; 1 mg/m3 VLE France - VLE: 0.1 ppm VLE; 1 mg/m3 VLE Germany: 0.1 ppm TWA; 1.1 mg/m3 TWA Germany: Skin absorber Japan: 0.1 ppm OEL; 1 mg/m3 OEL Malaysia: 0.1 ppm Ceiling; 1.0 mg/m3 Ceiling Russia: 1 mg/m3 TWA Spain: 0.1 ppm VLA-EC; 1 mg/m3 VLA-EC Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local explosion-proof ventilation to keep airborne levels to acceptable levels.
Exposure Limits CAS# 67-66-3: United Kingdom, WEL - TWA: 2 ppm TWA; 9.9 mg/m3 TWA United Kingdom, WEL - STEL: 6 ppm STEL; 29.7 mg/m3 STEL United States OSHA: ; 50 ppm Ceiling; 240 mg/m3 Ceiling Belgium - TWA: 10 ppm VLE; 50 mg/m3 VLE France - VME: 5 ppm VME; 25 mg/m3 VME France - VLE: 50 ppm VLE; 250 mg/m3 VLE Germany: 4 ppm TWA (large technical manufacture and use); 20 mg/m TWA (large technical m Germany: Skin absorber Japan: 10 ppm OEL; 49 mg/m3 OEL Malaysia: 10 ppm TWA; 49 mg/m3 TWA Netherlands: 5 ppm STEL; 25 mg/m3 STEL Netherlands: 1 ppm MAC; 5 mg/m3 MAC Spain: 2 ppm VLA-ED; 10 mg/m3 VLA-ED CAS# 107-21-1: United Kingdom, WEL - TWA: 20 ppm TWA (vapor); 52 mg/m3 TWA (vapo 10 mg/m3 TWA (particulate) United Kingdom, WEL - STEL: 40 ppm STEL (vapor); 104 mg/m3 STEL (vapor); 30 mg/m3 STEL (particulate) Belgium - TWA: 20 ppm VLE; 52 mg/m3 VLE Belgium - STEL: 40 ppm VLE; 104 mg/m3 VLE France - VLE: 50 ppm VLE (vapor); 125 mg/m3 VLE (vapor) Germany: 10 ppm TWA; 26 mg/m3 TWA Germany: Skin absorber Malaysia: 39.4 ppm Ceiling (aerosol); 100 mg/m3 Ceiling (aerosol) Netherlands: 40 ppm STEL; 104 mg/m3 STEL Netherlands: 20 ppm MAC (fume); 52 mg/m3 MAC (fume); 10 mg/m3 MAC (droplets) Russia: 5 mg/m3 TWA (aerosol, particulate, mist) Spain: 20 ppm VLA-ED; 52 mg/m3 VLA-ED Spain: 40 ppm VLA-EC; 104 mg/m3 VLA-EC CAS# 111-76-2: United Kingdom, WEL - TWA: 25 ppm TWA United Kingdom, WEL - STEL: 50 ppm STEL United States OSHA: 50 ppm TWA; 240 mg/m3 TWA Belgium - TWA: 20 ppm VLE; 98 mg/m3 VLE Belgium - STEL: 50 ppm VLE; 246 mg/m3 VLE France - VME: 25 ppm VME; 120 mg/m3 VME Germany: 20 ppm TWA; 98 mg/m3 TWA Germany: Skin absorber Malaysia: 20 ppm TWA; 96.7 mg/m3 TWA Netherlands: 50 ppm STEL; 246 mg/m3 STEL Netherlands: 20 ppm MAC; 100 mg/m3 MAC Russia: 5 mg/m3 TWA Spain: 20 ppm VLA-ED; 98 mg/m3 VLA-ED Spain: 50 ppm VLA-EC; 245 mg/m3 VLA-EC CAS# 5683-33-0: CAS# 7446-09-5: United States OSHA: 5 ppm TWA; 13 mg/m3 TWA Belgium - TWA: 2 ppm VLE; 5.3 mg/m3 VLE Belgium - STEL: 5 ppm VLE; 13 mg/m3 VLE France - VME: 2 ppm VME; 5 mg/m3 VME France - VLE: 5 ppm VLE; 10 mg/m3 VLE Germany: 1 ppm TWA (paper production, chemical and pharmaceutical industries); 2.5 mg/m3 Malaysia: 2 ppm TWA; 5.2 mg/m3 TWA Netherlands: 2 ppm MAC; 5 mg/m3 MAC Russia: 10 mg/m3 TWA Spain: 2 ppm VLA-ED; 5.3 mg/m3 VLA-ED Spain: 5 ppm VLA-EC; 13 mg/m3 VLA-EC CAS# 7553-56-2: United Kingdom, WEL - STEL: 0.1 ppm STEL; 1.1 mg/m3 STEL United States OSHA: ; 0.1 ppm Ceiling; 1 mg/m3 Ceiling Belgium - TWA: 0.1 ppm VLE; 1 mg/m3 VLE France - VLE: 0.1 ppm VLE; 1 mg/m3 VLE Germany: 0.1 ppm TWA; 1.1 mg/m3 TWA Germany: Skin absorber Japan: 0.1 ppm OEL; 1 mg/m3 OEL Malaysia: 0.1 ppm Ceiling; 1.0 mg/m3 Ceiling Russia: 1 mg/m3 TWA Spain: 0.1 ppm VLA-EC; 1 mg/m3 VLA-EC Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Liquid
Color: almost colorless
Odor: chloroform-like
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Slightly soluble.
Specific Gravity/Density:
Molecular Formula: Solution
Molecular Weight: 0
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Light, ignition sources, moisture, excess heat.
Incompatibilities with Other Materials:
Acetone, aluminum, active metals, strong oxidizing agents, sodium, strong bases, metals, plastics, rubber.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide, chlorine, phosgene gas.
Hazardous Polymerization: Has not been reported.
Stable under normal temperatures and pressures.
Conditions to Avoid:
Light, ignition sources, moisture, excess heat.
Incompatibilities with Other Materials:
Acetone, aluminum, active metals, strong oxidizing agents, sodium, strong bases, metals, plastics, rubber.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide, chlorine, phosgene gas.
Hazardous Polymerization: Has not been reported.
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 67-66-3: FS9100000 CAS# 107-21-1: KW2975000 CAS# 111-76-2: KJ8575000 CAS# 5683-33-0: US9200000 CAS# 7446-09-5: WS4550000 CAS# 7553-56-2: NN1575000 LD50/LC50:
CAS# 67-66-3: Draize test, rabbit, eye: 148 mg; Draize test, rabbit, eye: 20 mg/24H Moderate; Draize test, rabbit, skin: 500 mg/24H Mild; Inhalation, mouse: LC50 = 17200 mg/m3/2H; Inhalation, mouse: LC50 = 6000 mg/m3/6H; Inhalation, rat: LC50 = 47702 mg/m3/4H; Inhalation, rat: LC50 = 6000 mg/m3/6H; Oral, mouse: LD50 = 36 mg/kg; Oral, rat: LD50 = 695 mg/kg; Oral, rat: LD50 = 1250 mg/kg; Skin, rabbit: LD50 = >20 gm/kg.
CAS# 107-21-1: Draize test, rabbit, eye: 500 mg/24H Mild; Draize test, rabbit, eye: 100 mg/1H Mild; Draize test, rabbit, eye: 0.012 ppm/3D; Draize test, rabbit, eye: 1440 mg/6H Moderate; Oral, mouse: LD50 = 5500 mg/kg; Oral, rat: LD50 = 4700 mg/kg; Skin, rabbit: LD50 = 9530 uL/kg.
CAS# 111-76-2: Dermal, guinea pig: LD50 = 230 uL/kg; Draize test, rabbit, eye: 100 mg Severe; Draize test, rabbit, eye: 100 mg/24H Moderate; Inhalation, mouse: LC50 = 700 ppm/7H; Inhalation, mouse: LC50 = 3380 mg/m3/7H; Inhalation, rat: LC50 = 450 ppm/4H; Inhalation, rat: LC50 = 2900 mg/m3/7H; Oral, mouse: LD50 = 1230 mg/kg; Oral, mouse: LD50 = 1167 mg/kg; Oral, rabbit: LD50 = 300 mg/kg; Oral, rabbit: LD50 = 320 mg/kg; Oral, rat: LD50 = 470 mg/kg; Oral, rat: LD50 = 917 mg/kg; Skin, rabbit: LD50 = 220 mg/kg.
CAS# 5683-33-0.
CAS# 7446-09-5: Draize test, rabbit, eye: 6 ppm/32D Mild; Inhalation, mouse: LC50 = 3000 ppm/30M; Inhalation, rat: LC50 = 2520 ppm/1H; Inhalation, rat: LC50 = 2168 mg/m3.
CAS# 7553-56-2: Oral, mouse: LD50 = 22 gm/kg; Oral, mouse: LD50 = 1000 mg/kg; Oral, rabbit: LD50 = 10 gm/kg; Oral, rat: LD50 = 14 gm/kg.
Carcinogenicity:
Chloroform - ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to California: carcinogen, initial date 10/1/87 NTP: Suspect carcinogen IARC: Group 2B carcinogen Ethylene glycol - Not listed by ACGIH, IARC, or NTP.
2-Butoxyethanol - ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to 2-Dimethylaminopyridine - Not listed by ACGIH, IARC, or NTP.
Sulfur dioxide - Not listed by ACGIH, IARC, or NTP.
Iodine - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
CAS# 67-66-3: FS9100000 CAS# 107-21-1: KW2975000 CAS# 111-76-2: KJ8575000 CAS# 5683-33-0: US9200000 CAS# 7446-09-5: WS4550000 CAS# 7553-56-2: NN1575000 LD50/LC50:
CAS# 67-66-3: Draize test, rabbit, eye: 148 mg; Draize test, rabbit, eye: 20 mg/24H Moderate; Draize test, rabbit, skin: 500 mg/24H Mild; Inhalation, mouse: LC50 = 17200 mg/m3/2H; Inhalation, mouse: LC50 = 6000 mg/m3/6H; Inhalation, rat: LC50 = 47702 mg/m3/4H; Inhalation, rat: LC50 = 6000 mg/m3/6H; Oral, mouse: LD50 = 36 mg/kg; Oral, rat: LD50 = 695 mg/kg; Oral, rat: LD50 = 1250 mg/kg; Skin, rabbit: LD50 = >20 gm/kg.
CAS# 107-21-1: Draize test, rabbit, eye: 500 mg/24H Mild; Draize test, rabbit, eye: 100 mg/1H Mild; Draize test, rabbit, eye: 0.012 ppm/3D; Draize test, rabbit, eye: 1440 mg/6H Moderate; Oral, mouse: LD50 = 5500 mg/kg; Oral, rat: LD50 = 4700 mg/kg; Skin, rabbit: LD50 = 9530 uL/kg.
CAS# 111-76-2: Dermal, guinea pig: LD50 = 230 uL/kg; Draize test, rabbit, eye: 100 mg Severe; Draize test, rabbit, eye: 100 mg/24H Moderate; Inhalation, mouse: LC50 = 700 ppm/7H; Inhalation, mouse: LC50 = 3380 mg/m3/7H; Inhalation, rat: LC50 = 450 ppm/4H; Inhalation, rat: LC50 = 2900 mg/m3/7H; Oral, mouse: LD50 = 1230 mg/kg; Oral, mouse: LD50 = 1167 mg/kg; Oral, rabbit: LD50 = 300 mg/kg; Oral, rabbit: LD50 = 320 mg/kg; Oral, rat: LD50 = 470 mg/kg; Oral, rat: LD50 = 917 mg/kg; Skin, rabbit: LD50 = 220 mg/kg.
CAS# 5683-33-0.
CAS# 7446-09-5: Draize test, rabbit, eye: 6 ppm/32D Mild; Inhalation, mouse: LC50 = 3000 ppm/30M; Inhalation, rat: LC50 = 2520 ppm/1H; Inhalation, rat: LC50 = 2168 mg/m3.
CAS# 7553-56-2: Oral, mouse: LD50 = 22 gm/kg; Oral, mouse: LD50 = 1000 mg/kg; Oral, rabbit: LD50 = 10 gm/kg; Oral, rat: LD50 = 14 gm/kg.
Carcinogenicity:
Chloroform - ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to California: carcinogen, initial date 10/1/87 NTP: Suspect carcinogen IARC: Group 2B carcinogen Ethylene glycol - Not listed by ACGIH, IARC, or NTP.
2-Butoxyethanol - ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to 2-Dimethylaminopyridine - Not listed by ACGIH, IARC, or NTP.
Sulfur dioxide - Not listed by ACGIH, IARC, or NTP.
Iodine - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
Ecotoxicity:
Cas# 107-21-1: LC50 (96Hr.)rainbow trout = 41000 mg/L; 20 degrees C LC50(96Hr.)bluegill = 27500-41000 mg/L LC50(96Hr.)goldfish = 27500-41000 mg/L LC50(48Hr.)water flea = 46300 mg/L EC50(30 minutes)Photobacterium phosphoreum = 3038 mg/L; Microtox test
Cas# 107-21-1: LC50 (96Hr.)rainbow trout = 41000 mg/L; 20 degrees C LC50(96Hr.)bluegill = 27500-41000 mg/L LC50(96Hr.)goldfish = 27500-41000 mg/L LC50(48Hr.)water flea = 46300 mg/L EC50(30 minutes)Photobacterium phosphoreum = 3038 mg/L; Microtox test
Section 13 - DISPOSAL CONSIDERATIONS
Products which are considered hazardous for supply are classified as Special Waste and the disposal of such chemicals is covered by regulations which may vary according to location. Contact a specialist disposal company or the local waste regulator for advice. Empty containers must be decontaminated before returning for recycling.
Section 14 - TRANSPORT INFORMATION
IATA
Shipping Name: TOXIC LIQUIDS, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
IMO
Shipping Name: TOXIC LIQUIDS, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
RID/ADR
Shipping Name: TOXIC LIQUIDS, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing group: III
USA RQ: CAS# 67-66-3: 10 lb final RQ; 4.54 kg final RQ
USA RQ: CAS# 107-21-1: 5000 lb final RQ; 2270 kg final RQ
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 37/38 Irritating to respiratory system and skin.
R 40 Limited evidence of a carcinogenic effect.
R 48/20/22 Harmful : danger of serious damage to
health by prolonged exposure through inhalation and if
swallowed.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
S 46 If swallowed, seek medical advice immediately
and show this container or label.
WGK (Water Danger/Protection)
CAS# 67-66-3: 3
CAS# 107-21-1: 0
CAS# 111-76-2: 1
CAS# 5683-33-0: No information available.
CAS# 7446-09-5: 1
CAS# 7553-56-2: 1
Canada
CAS# 67-66-3 is listed on Canadas DSL List.
CAS# 107-21-1 is listed on Canadas DSL List.
CAS# 111-76-2 is listed on Canadas DSL List.
CAS# 7446-09-5 is listed on Canadas DSL List.
CAS# 7553-56-2 is listed on Canadas DSL List.
CAS# 67-66-3 is listed on Canadas Ingredient Disclosure List.
CAS# 107-21-1 is listed on Canadas Ingredient Disclosure List.
CAS# 111-76-2 is listed on Canadas Ingredient Disclosure List.
CAS# 5683-33-0 is not listed on Canadas Ingredient Disclosure List.
CAS# 7446-09-5 is listed on Canadas Ingredient Disclosure List.
CAS# 7553-56-2 is listed on Canadas Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 67-66-3 is listed on the TSCA inventory.
CAS# 107-21-1 is listed on the TSCA inventory.
CAS# 111-76-2 is listed on the TSCA inventory.
CAS# 5683-33-0 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 7446-09-5 is listed on the TSCA inventory.
CAS# 7553-56-2 is listed on the TSCA inventory.
